ADCT vs IEX · rev $40.1M vs P/E 29, rev $1.81B
ADC Therapeutics SA (ADCT) versus IDEX Corporation (IEX) — a side-by-side from cached financials, not a winner call.
ADC Therapeutics SA (ADCT) is a biotechnology company listed on NYSE.
IDEX Corporation (IEX) is a specialty industrial machinery company listed on US.
Latest reported ADCT revenue for 2026-06-30 was $40.1M. Net income was -$49.5M. Revenue was up 92.3% from 2026-03-31 to 2026-06-30. ADCT currently screens at market cap $141.2M.
Latest reported IEX revenue for 2026-06-30 was $1.81B. Net income was $263.4M. IEX currently screens at market cap $13.71B and trailing P/E 28.8.
ADCT currently screens at market cap $141.2M. IEX currently screens at market cap $13.71B and trailing P/E 28.8.
Not investment advice. Open the ADCT and IEX stock pages for the full models.
Not investment advice.